Literature DB >> 33563896

Serum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow up.

Elisabet E Manasanch1, Chutima Kunacheewa2,3, Catherine M Claussen2, Hans C Lee2, Sheeba K Thomas2, Jill Gunther4, Chelsea C Pinnix4, Bouthaina S Dabaja4, Behrang Amini5, Raymond Alexanian2, Robert Z Orlowski2, Wenli Dong6, Lei Feng6, Donna M Weber2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33563896      PMCID： PMC7873072          DOI： 10.1038/s41408-021-00419-1

Source DB:  PubMed          Journal:  Blood Cancer J        ISSN： 2044-5385            Impact factor:   11.037


× No keyword cloud information.
  14 in total

1.  New insights in the treatment of patients with solitary bone plasmacytoma.

Authors:  Kayane Mheidly; Thierry Lamy De La Chapelle; Mathilde Hunault; Lotfi Benboubker; Mohamed Benchalal; Philippe Moreau; Alix Baugier de Materre; Olivier Decaux; Kamel Laribi
Journal:  Leuk Lymphoma       Date:  2019-04-25

Review 2.  International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

Authors:  S Vincent Rajkumar; Meletios A Dimopoulos; Antonio Palumbo; Joan Blade; Giampaolo Merlini; María-Victoria Mateos; Shaji Kumar; Jens Hillengass; Efstathios Kastritis; Paul Richardson; Ola Landgren; Bruno Paiva; Angela Dispenzieri; Brendan Weiss; Xavier LeLeu; Sonja Zweegman; Sagar Lonial; Laura Rosinol; Elena Zamagni; Sundar Jagannath; Orhan Sezer; Sigurdur Y Kristinsson; Jo Caers; Saad Z Usmani; Juan José Lahuerta; Hans Erik Johnsen; Meral Beksac; Michele Cavo; Hartmut Goldschmidt; Evangelos Terpos; Robert A Kyle; Kenneth C Anderson; Brian G M Durie; Jesus F San Miguel
Journal:  Lancet Oncol       Date:  2014-10-26       Impact factor: 41.316

3.  Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.

Authors:  María-Victoria Mateos; Miguel-Teodoro Hernández; Pilar Giraldo; Javier de la Rubia; Felipe de Arriba; Lucía López Corral; Laura Rosiñol; Bruno Paiva; Luis Palomera; Joan Bargay; Albert Oriol; Felipe Prosper; Javier López; Eduardo Olavarría; Nuria Quintana; José-Luis García; Joan Bladé; Juan-José Lahuerta; Jesús-F San Miguel
Journal:  N Engl J Med       Date:  2013-08-01       Impact factor: 91.245

4.  Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients.

Authors:  Mahmut Ozsahin; Richard W Tsang; Philip Poortmans; Yazid Belkacémi; Michel Bolla; Fazilet Oner Dinçbas; Christine Landmann; Bernard Castelain; Jeroen Buijsen; Jürgen Curschmann; Sidney P Kadish; Anna Kowalczyk; Yavuz Anacak; Josef Hammer; Tan D Nguyen; Gabriela Studer; Rachel Cooper; Meriç Sengöz; Luciano Scandolaro; Abderrahim Zouhair
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-17       Impact factor: 7.038

5.  Improved outcome in solitary bone plasmacytomata with combined therapy.

Authors:  A Avilés; J Huerta-Guzmán; S Delgado; A Fernández; J C Díaz-Maqueo
Journal:  Hematol Oncol       Date:  1996-09       Impact factor: 5.271

6.  Curability of solitary bone plasmacytoma.

Authors:  M A Dimopoulos; J Goldstein; L Fuller; K Delasalle; R Alexanian
Journal:  J Clin Oncol       Date:  1992-04       Impact factor: 44.544

7.  Plasmacytoma. Treatment results and conversion to myeloma.

Authors:  J Holland; D A Trenkner; T H Wasserman; B Fineberg
Journal:  Cancer       Date:  1992-03-15       Impact factor: 6.860

8.  Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma.

Authors:  Bruno Paiva; Mauricio Chandia; Maria-Belen Vidriales; Enrique Colado; Teresa Caballero-Velázquez; Fernando Escalante; Alfonso Garcia de Coca; Maria-Carmen Montes; Ramon Garcia-Sanz; Enrique M Ocio; Maria-Victoria Mateos; Jesus F San Miguel
Journal:  Blood       Date:  2014-05-29       Impact factor: 22.113

9.  Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study.

Authors:  David Knobel; Abderrahim Zouhair; Richard W Tsang; Philip Poortmans; Yazid Belkacémi; Michel Bolla; Fazilet Dinçbas Oner; Christine Landmann; Bernard Castelain; Mahmut Ozsahin
Journal:  BMC Cancer       Date:  2006-05-05       Impact factor: 4.430

10.  Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone.

Authors:  L Y Shih; P Dunn; W M Leung; W J Chen; P N Wang
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640
View more
  2 in total

1.  An Unusual Case of Multiple Myeloma with Light-Chain Cast Nephropathy Secondary to a Very Large Plasmacytoma without Bone Marrow Involvement.

Authors:  Justin Komisarof; Jodi Lipof; Joseph DiTursi; Amit Chowdhry; Hae Yoon Grace Choung; W Richard Burack; Louis Constine; Frank Passero
Journal:  Case Rep Hematol       Date:  2022-02-21

2.  Solitary Primary Intracranial Extramedullary Plasmacytoma With Lymph Node Metastasis.

Authors:  Anna-Lena Meinhardt; Christopher W Sandifer; Manish Dave
Journal:  Cureus       Date:  2022-04-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.